The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 25, 2010

Filed:

Nov. 04, 2002
Applicants:

Leonard A. Herzenberg, Stanford, CA (US);

Leonore A. Herzenberg, Stanford, CA (US);

Stephen C. DE Rosa, Seattle, WA (US);

James Andrus, Redwood City, CA (US);

Inventors:

Leonard A. Herzenberg, Stanford, CA (US);

Leonore A. Herzenberg, Stanford, CA (US);

Stephen C. De Rosa, Seattle, WA (US);

James Andrus, Redwood City, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/195 (2006.01); A61K 31/65 (2006.01); A61K 31/63 (2006.01); A61K 31/60 (2006.01); A61K 31/43 (2006.01); A61K 31/545 (2006.01);
U.S. Cl.
CPC ...
Abstract

The invention provides pharmaceutical compositions for the treatment or prevention of the toxic effects of therapeutic agents and methods of treating or preventing such toxicity using a toxicity reducing amount of N-acetylcysteine either alone or in combination with a therapeutically effective amount or, to achieve its therapeutic advantages, an amount larger than what is customarily given as a therapeutically effective amount, of a therapeutic agent. The invention also provides pharmaceutical compositions for the treatment or prevention of the toxic effects of therapeutic agents and methods of treating or preventing such toxicity using a toxicity reducing amount of N-acetylcysteine either alone or in combination with a therapeutically effective amount or, to achieve its therapeutic advantages, an amount larger than what is customarily given as a therapeutically effective amount, of a therapeutic agent whose side effects are made worse by increased oxidative stress or treatment related decreases in subject cysteine/glutathione levels or are otherwise relieved by administration of NAC.


Find Patent Forward Citations

Loading…